In vitro PKA phosphorylation-mediated human PDE4A4 activation
- PMID: 11852080
- DOI: 10.1016/s0014-5793(02)02259-7
In vitro PKA phosphorylation-mediated human PDE4A4 activation
Abstract
The PDE4 catalytic machinery comprises, in part, two divalent cations in a binuclear motif. Here we report that PDE4A4 expressed in Sf9 cells exhibits a biphasic Mg(2+) dose-response (EC(50) of 0.15 and >10 mM) in catalyzing cAMP hydrolysis. In vitro phosphorylation of PDE4A4 by the PKA-catalytic subunit increases the enzyme's sensitivity to Mg(2+), leading to 4-fold increased cAMP hydrolysis without affecting its K(m). The phosphorylation also increases the potencies of (R)- and (S)-rolipram without affecting CDP-840 and SB-207499. The results support that modulating the cofactor binding affinity of PDE4 represents a mechanism for regulating its activity.
Similar articles
-
Dissecting the cofactor-dependent and independent bindings of PDE4 inhibitors.Biochemistry. 2001 Aug 28;40(34):10179-86. doi: 10.1021/bi010096p. Biochemistry. 2001. PMID: 11513595
-
Occupancy of the catalytic site of the PDE4A4 cyclic AMP phosphodiesterase by rolipram triggers the dynamic redistribution of this specific isoform in living cells through a cyclic AMP independent process.Cell Signal. 2003 Oct;15(10):955-71. doi: 10.1016/s0898-6568(03)00092-5. Cell Signal. 2003. PMID: 12873709
-
In resting COS1 cells a dominant negative approach shows that specific, anchored PDE4 cAMP phosphodiesterase isoforms gate the activation, by basal cyclic AMP production, of AKAP-tethered protein kinase A type II located in the centrosomal region.Cell Signal. 2005 Sep;17(9):1158-73. doi: 10.1016/j.cellsig.2005.04.003. Cell Signal. 2005. PMID: 15905070
-
PDE4 cAMP-specific phosphodiesterases.Prog Nucleic Acid Res Mol Biol. 2001;69:249-315. doi: 10.1016/s0079-6603(01)69049-4. Prog Nucleic Acid Res Mol Biol. 2001. PMID: 11550796 Review. No abstract available.
-
Negative regulation of T-cell receptor activation by the cAMP-PKA-Csk signalling pathway in T-cell lipid rafts.Front Biosci. 2006 Sep 1;11:2929-39. doi: 10.2741/2022. Front Biosci. 2006. PMID: 16720365 Review.
Cited by
-
Analysis of (R)- and (S)-[(11)C]rolipram kinetics in canine myocardium for the evaluation of phosphodiesterase-4 with PET.Mol Imaging Biol. 2012 Apr;14(2):225-36. doi: 10.1007/s11307-011-0482-6. Mol Imaging Biol. 2012. PMID: 21424298
-
The therapeutic profile of rolipram, PDE target and mechanism of action as a neuroprotectant following spinal cord injury.PLoS One. 2012;7(9):e43634. doi: 10.1371/journal.pone.0043634. Epub 2012 Sep 19. PLoS One. 2012. PMID: 23028463 Free PMC article.
-
Computational Modeling Reveals Frequency Modulation of Calcium-cAMP/PKA Pathway in Dendritic Spines.Biophys J. 2019 Nov 19;117(10):1963-1980. doi: 10.1016/j.bpj.2019.10.003. Epub 2019 Oct 9. Biophys J. 2019. PMID: 31668749 Free PMC article.
-
Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.Physiol Rev. 2018 Apr 1;98(2):919-1053. doi: 10.1152/physrev.00025.2017. Physiol Rev. 2018. PMID: 29537337 Free PMC article. Review.
-
Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis.J Clin Invest. 2002 Oct;110(7):1045-52. doi: 10.1172/JCI15506. J Clin Invest. 2002. PMID: 12370283 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases